Skyward Specialty Insurance Group Earnings Calls
| Release date | May 06, 2026 |
| EPS estimate | $1.11 |
| EPS actual | $1.25 |
| EPS Surprise | 12.61% |
| Revenue estimate | 665.12M |
| Revenue actual | 667.704M |
| Revenue Surprise | 0.388% |
| Release date | Feb 23, 2026 |
| EPS estimate | $0.96 |
| EPS actual | $1.17 |
| EPS Surprise | 21.88% |
| Revenue estimate | 434.077M |
| Revenue actual | 439.581M |
| Revenue Surprise | 1.27% |
| Release date | Oct 29, 2025 |
| EPS estimate | $0.85 |
| EPS actual | $0.710 |
| EPS Surprise | -16.47% |
| Revenue estimate | 380.287M |
| Revenue actual | 382.181M |
| Revenue Surprise | 0.498% |
| Release date | Jul 30, 2025 |
| EPS estimate | $0.86 |
| EPS actual | $0.89 |
| EPS Surprise | 3.49% |
| Revenue estimate | 335.277M |
| Revenue actual | 320.801M |
| Revenue Surprise | -4.32% |
Last 4 Quarters for Skyward Specialty Insurance Group
Below you can see how SKWD performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 30, 2025 |
| Price on release | $49.44 |
| EPS estimate | $0.86 |
| EPS actual | $0.89 |
| EPS surprise | 3.49% |
| Date | Price |
|---|---|
| Jul 24, 2025 | $51.80 |
| Jul 25, 2025 | $51.98 |
| Jul 28, 2025 | $51.02 |
| Jul 29, 2025 | $50.91 |
| Jul 30, 2025 | $49.44 |
| Jul 31, 2025 | $50.58 |
| Aug 01, 2025 | $49.39 |
| Aug 04, 2025 | $49.57 |
| Aug 05, 2025 | $48.13 |
| 4 days before | -4.56% |
| 4 days after | -2.65% |
| On release day | 2.31% |
| Change in period | -7.08% |
| Release date | Oct 29, 2025 |
| Price on release | $45.01 |
| EPS estimate | $0.85 |
| EPS actual | $0.710 |
| EPS surprise | -16.47% |
| Date | Price |
|---|---|
| Oct 23, 2025 | $46.60 |
| Oct 24, 2025 | $46.34 |
| Oct 27, 2025 | $46.76 |
| Oct 28, 2025 | $45.14 |
| Oct 29, 2025 | $45.01 |
| Oct 30, 2025 | $45.64 |
| Oct 31, 2025 | $45.59 |
| Nov 03, 2025 | $45.02 |
| Nov 04, 2025 | $45.87 |
| 4 days before | -3.41% |
| 4 days after | 1.91% |
| On release day | 1.40% |
| Change in period | -1.57% |
| Release date | Feb 23, 2026 |
| Price on release | $47.16 |
| EPS estimate | $0.96 |
| EPS actual | $1.17 |
| EPS surprise | 21.88% |
| Date | Price |
|---|---|
| Feb 17, 2026 | $46.07 |
| Feb 18, 2026 | $45.18 |
| Feb 19, 2026 | $45.84 |
| Feb 20, 2026 | $46.88 |
| Feb 23, 2026 | $47.16 |
| Feb 24, 2026 | $45.07 |
| Feb 25, 2026 | $45.89 |
| Feb 26, 2026 | $45.00 |
| Feb 27, 2026 | $46.47 |
| 4 days before | 2.37% |
| 4 days after | -1.46% |
| On release day | -4.43% |
| Change in period | 0.87% |
| Release date | May 06, 2026 |
| Price on release | $43.84 |
| EPS estimate | $1.11 |
| EPS actual | $1.25 |
| EPS surprise | 12.61% |
| Date | Price |
|---|---|
| Apr 30, 2026 | $45.45 |
| May 01, 2026 | $45.44 |
| May 04, 2026 | $43.64 |
| May 05, 2026 | $43.93 |
| May 06, 2026 | $43.84 |
| May 07, 2026 | $45.51 |
| May 08, 2026 | $46.69 |
| May 11, 2026 | $45.84 |
| May 12, 2026 | $45.37 |
| 4 days before | -3.54% |
| 4 days after | 3.49% |
| On release day | 3.81% |
| Change in period | -0.176% |
Skyward Specialty Insurance Group Earnings Call Transcript Summary of Q1 2026
Skyward Specialty reported a strong first quarter as a combined company with Apollo. Operating diluted EPS was $1.25, up 39% year-over-year, and annualized operating ROE was ~20%. Book value per share rose to $27.50 (up 10% quarter-over-quarter and ~31% year-over-year). Gross written premiums were $668 million (≈10% pro forma growth) while managed premiums — a key metric for fee income — were $968 million (≈20% pro forma growth), including $300 million of fee-generating premiums (up ~49%). Underwriting income was $52 million and consolidated combined ratio was 89.5 (1.8 pts of catastrophe); ex-cat combined ratio was 87.7. Skyward segment combined ratio was 88.9 (86.8 ex-cat) and Apollo posted a combined ratio of 85.3 with a notably low non-cat loss ratio (52.8) in Q1 due to mix/seasonality. Investment portfolio is about $2.7 billion (≈90% fixed income/short-term), embedded yield ~5.3%, and net investment income improved to $27 million. There was no prior accident year development. Company reaffirmed 2026 guidance. Strategic takeaways: (1) Apollo acquisition is accretive and adds a scalable, capital-light fee engine; (2) management emphasizes a differentiated, niche-focused, cycle-resistant portfolio with >50% of business in areas less exposed to broad P&C cycles (A&H, surety, credit, agriculture, Lloyd’s syndicates 1969/1971, etc.); (3) new initiatives include autonomous vehicle insurance (Uber), a life sciences Lloyd’s offering, Syndicate 1972 (internal reinsurance sidecar), and iBot/1971 growth; (4) management remains disciplined on underwriting and reinsurance placement even as parts of the property/reinsurance markets soften and competition intensifies. Key risks/monitoring items for investors: property market deterioration/softening, evolving reinsurance pricing and structures, marks/volatility in alternative investments, and potential mix/seasonality effects from London syndicates.
Sign In
Buy SKWD